Managing Cancer Grand Challenges funding
This page is for researchers funded through Cancer Grand Challenges, prospective and current applicants for funding, and their host institutions. It contains all relevant contractual documentation and guidance for managing Cancer Grand Challenges funding.
Key documents
When receiving Cancer Grand Challenges funding, all investigators and institutions participating in a team are required to sign up to a Cancer Grand Challenges Award Agreement, also signed by the research funders: Cancer Research UK and the NCI.
The Award Agreement incorporates the terms outlined in the Award Management and Funding Policy Guide, Commercialisation Policy, Cancer Research UK Allowable Costs Guidance and National Cancer Institute Other Transaction Award Policy Guide.You can access all of these documents below.
Each funded institution will also be subject to specific terms detailed in their Notice of Award and Grant Award Letter. All contractual documents may be updated from time to time, and the most up-to-date versions will be posted here.
Cancer Grand Challenges Award Agreement:
This is the lead contracting document to be signed by all parties within a team
Award Management & Funding Policy Guide:
This document is a guide to the management of Cancer Grand Challenges awards starting in 2022 and beyond.
Commercialisation Policy:
This document outlines the commercialisation process entered into by all parties
Cancer Research UK Allowable Costs Guidance:
This document provides terms relevant only to the Cancer Research UK portion of funding
Cancer Grand Challenges & National Cancer Institute Other Transaction Award Policy Guide:
NCI will issue Cancer Grand Challenges awards to Institutions using the NIH Other Transaction (OT) Authority, granted under Section 402(n) of the Public Health Service Act. This document outlines terms specific to this.